Renal Doppler in Pediatric Patients With Idiopathic Nephrotic Syndrome

NCT05912673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-01-24

No results posted yet for this study

Summary

The use of the renal resistive index in pediatric patient with idiopathic nephrotic syndrome to detect steroid resistance and to use it as a prognostic instrument of the progression of the disease.

Conditions

  • Nephrotic Syndrome

Interventions

DEVICE

renal doppler

Toshiba Aplio ultrasound machine and renal resistive index will be measured (peak systolic velocity- end diastolic velocity/ peak systolic velocity

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sara Mabrouk Mohamed Elghoul, MD · Tanta University

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-28
Primary Completion
2023-07-30
Completion
2023-08-30
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05912673 on ClinicalTrials.gov